L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For Africa and Arab States
Prof. Khalid Mohammed AlGhamdi from Saudi Arabia
Charity Society known as Faal to empower and support vitiligo patients in Saudi Arabia
Vitiligo is a long-term skin condition that causes pale, white patches on the skin due to a lack of melanin. This project aimed to increase awareness via TV broadcasts, schools visits and to provide psychological and social support to patients with vitiligo through training courses and different education programs.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
This week Hill-Rom (NYSE: HRC) is featuring the Progressa® bed system, the next generation of intensive care unit (ICU) bed systems, at the American Organization of Nurse Executives (AONE) annual meeting in Orlando, Fla. The Progressa bed system is a therapeutic system designed to treat and prevent complications of immobility. It features a state-of-the-art design that supports treatment goals and was engineered to help address patient migration via its StayInPlace™ technology.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/66137-hill-rom-new-progressa-bed-system
The Alfred Mann Foundation (AMF) today announced the first subject, a U.S. Marine, SSgt James Sides, as a recipient of its highly anticipated IMES System (implantable myoelectric sensor) – an experimental system that holds the promise of being the first minimally invasive, intuitive, multi-channel control system for prosthetics intended for long term use. The IMES System is currently being studied under the Investigational Device Exemption (IDE) regulations of the U.S. Food and Drug Administration (FDA). AMF’s ongoing trial with injured veterans at the Walter Reed National Medical Military Center anticipates subjects intuitively operating three different prosthetic movements simultaneously: opening and closing the hand, rotating the wrist, and moving the thumb. Combining these three movements enables several grasps that are invaluable for performing everyday tasks.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65112-alfred-mann-foundation-u-s-marine-subject-fda-study-for-imes-system
Fresh videos, information and links relating to the stress experienced by America's 15 million+ family caregivers for people with dementia are now available in the Brookdale Alzheimer's Resource Center. The new topics include:
A woman describing the impact of her mother-in-law's dementia on her family: Video
How spouses and adult children experience caregiving differently: Video and text document
Ways that caregivers can protect their own brain health: Text document
Long-distance caregiving, the symptoms of caregiving stress, dealing with caregiver guilt, being a healthy caregiver and caring for the caregiver: Links to information and a webinar
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7087731-brookdale-senior-living/
Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia. In one long-term study of pediatric patients with acute lymphoblastic leukemia (ALL), results showed that 36 of 39 pediatric patients with relapsed/refractory (r/r) ALL, or 92%, experienced complete remissions (CR) with CTL0191.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7393851-novartis-new-ctl019-clinic-data-acute-lymphoblastic-leukemia/
Today, SunPower introduces the SunPower Equinox™ system, now available to U.S. homeowners. It is the first residential solar solution in the nation in which every major component has been designed and engineered by one company to work seamlessly together, delivering unbeatable power, long-term performance and curb appeal. With a typical SunPower Equinox installation, only the solar panels and a Smart Energy management device are visible, reflecting SunPower’s minimalist architectural approach at the system level.
The SunPower Equinox platform was engineered based on the company’s The Power of One™ philosophy, which drives innovation of preconfigured solutions that simplify solar for consumers. In 2010, SunPower introduced its Oasis® Power Plant, the world’s first fully integrated utility solar platform, which enables rapid, cost-effective construction of large-scale power plants, now with over 1.8 gigawatts deployed. In 2015, SunPower introduced the industry’s first fully integrated solar solution for commercial customers, the SunPower® Helix™ system, which can be installed on commercial rooftops more than 2.5 times faster than any commercial solar solution on the market. Now, the SunPower Equinox™ system brings The Power of One™ to homeowners.
To view the multimedia release go to:
http://www.multivu.com/players/English/7706152-sunpower-reinvents-home-solar-equinox/
A new survey from the Gout & Uric Acid Education Society (GUAES) finds many Americans with gout may be placing too much emphasis on diet when it comes to managing the disease and controlling painful flares. Of all the steps taken to manage gout, respondents cited changing their diet by eliminating or reducing consumption of certain foods as their top step taken (50 percent)—even ahead of taking medications to lower their uric acid levels (40 percent) and maintaining an overall healthy fitness level (33 percent). Furthermore, nearly one in three with gout incorrectly believes that the disease can be completely avoided by eliminating certain foods; and more than one in four said they would not take medications if they were making dietary changes.
“Physicians all too often see patients who believe they can successfully manage their gout with diet alone,” said N. Lawrence Edwards, M.D., a rheumatologist and GUAES chairman. “But even with extremely rigid diet restrictions, most gout patients will only be able to lower their uric acid levels slightly—not nearly enough to achieve a healthy level to control flares and reduce risk for long-term damage.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7835451-guaes-diet-survey/
Huawei, a leading global information and communications technology (ICT) solution provider, unveiled its FusionCube for SAP HANA solution for Sinopec at the CeBIT 2015 today.
Sinopec is one of the world's largest integrated energy and chemical Groups, ranking No.3 in Fortune Global 500 in 2014. With continuous expansion of Sinopec's services, the financial report system data rapidly increases. “With the increasing applications in these years, our user base and service plane grow continuously and more and more data needs to be processed. In the era of Big Data, efficiency data processing and analysis was high on the agenda." said Li Jianfeng, Deputy Director of the Information Management Department of Sinopec, "We decided to use SAP Enterprise Data Warehouse (EDW) HANA after comparison. But this technology cannot work without a hardware platform. Finally, we chose Huawei as our long-term partner to test and optimize the platform."
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7479051-huawei-joined-hands-with-SAP/
On July 21, 2014, Genworth (NYSE:GNW) is introducing Privileged Choice® Flex 3 featuring FlexFit℠ packages. FlexFit packages are designed to help address the primary barriers to purchasing long term care insurance – price and complexity. FlexFit gives millions more Americans the flexibility to choose the right fit for their long term care needs, combined with the simplicity of prepackaged benefits. Privileged Choice Flex 3 is issued by Genworth Life Insurance Company.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7206252-genworth-offers-affordable-flexfit-long-term-life-insurance/
Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols.
When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
Today, GENYOUth announced the launch of Fuel Up to Play 60 en español, an evolution of its national flagship program. The program encourages Spanish-speaking communities nationwide to live healthier lifestyles through good nutrition and physical activity. Fuel Up to Play 60 launched a redesigned website (FuelUpToPlay60.com) that provides Spanish-language content and materials, extending the reach and access of the program to students, teachers and families across the country. Several organizations have supported the effort, including the PepsiCo Foundation, which has provided a previously announced grant of $550,000 to develop Spanish-language materials and resources. In addition the PepsiCo Foundation will provide another $100,000 for mini-grants for health and wellness activities and programming within Los Angeles Unified School District and Miami-Dade County Public Schools.
Fuel Up to Play 60, a program founded by the National Football League (NFL) and National Dairy Council (NDC), is designed to engage and empower youth to take action for their own health by implementing long-term, positive nutrition and physical activity changes for themselves, their schools and their communities. Studies show that physical fitness may benefit brain health and academic performance, suggesting active kids may do better. However, only 1 in 3 kids are active every day, potentially leaving many at a disadvantage inside and outside of the classroom.
To view the multimedia release go to:
http://www.multivu.com/players/English/7646551-fuel-up-to-play-60/
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
